Dr. Reddy’s to delay semaglutide supplies due to quality issue, shares hit
Dr. Reddy’s Laboratories. File | Photo Credit: The Hindu Dr. Reddy’s Laboratories on Thursday (July 9, 2026) said it has halted commercial supplies of its generic semaglutide after an issue associated with the active pharmaceutical ingredient (API) used in the drug, and fresh despatches were likely to resume only towards late October or early November….
Read More “Dr. Reddy’s to delay semaglutide supplies due to quality issue, shares hit” »